Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for CNC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 -259.00M
March 31, 2026 -1.063B
December 31, 2025 -187.00M
September 30, 2025 9.00M
June 30, 2025 -1.174B
March 31, 2025 -250.00M
December 31, 2024 -13.00M
September 30, 2024 -1.245B
June 30, 2024 -1.171B
March 31, 2024 23.00M
December 31, 2023 -200.00M
September 30, 2023 -522.00M
June 30, 2023 -723.00M
March 31, 2023 -125.00M
December 31, 2022 -1.732B
September 30, 2022 -1.481B
June 30, 2022 -486.00M
March 31, 2022 -498.00M
December 31, 2021 -235.00M
September 30, 2021 1.643B
June 30, 2021 27.00M
March 31, 2021 -73.00M
December 31, 2020 -123.00M
September 30, 2020 4.00M
June 30, 2020 -460.00M
Date Value
March 31, 2020 839.00M
December 31, 2019 6.683B
September 30, 2019 -108.00M
June 30, 2019 178.00M
March 31, 2019 58.00M
December 31, 2018 163.00M
September 30, 2018 82.00M
June 30, 2018 3.928B
March 31, 2018 513.00M
December 31, 2017 -46.00M
September 30, 2017 -9.00M
June 30, 2017 49.00M
March 31, 2017 -10.00M
December 31, 2016 109.00M
September 30, 2016 116.00M
June 30, 2016 161.00M
March 31, 2016 2.331B
December 31, 2015 -71.00M
September 30, 2015 104.00M
June 30, 2015 25.00M
March 31, 2015 236.00M
December 31, 2014 -75.69M
September 30, 2014 74.69M
June 30, 2014 67.65M
March 31, 2014 125.35M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
The Cigna Group 207.00M
CVS Health Corp. -2.693B
Humana, Inc. 249.00M
Molina Healthcare, Inc. -4.00M
UnitedHealth Group, Inc. -8.623B